Targeting cardiac hypertrophy through a nuclear co‐repressor
Heart failure entails the inability of the heart to pump blood to vital organs. One of the main risk factors for heart failure is the development of pathological hypertrophy. In this issue of EMBO Molecular Medicine, Li and coworkers show that NCoR1, a co‐repressor of transcription factors, inhibits...
Main Authors: | Andrea Grund, Joerg Heineke |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2019-11-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.15252/emmm.201911297 |
Similar Items
-
Nuclear receptor corepressor 1 represses cardiac hypertrophy
by: Chao Li, et al.
Published: (2019-11-01) -
TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation
by: Andrea Grund, et al.
Published: (2019-10-01) -
Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy
by: G. Ian Gallicano, et al.
Published: (2022-07-01) -
FGF23-Mediated Activation of Local RAAS Promotes Cardiac Hypertrophy and Fibrosis
by: Ineke Böckmann, et al.
Published: (2019-09-01) -
Yeast importin-β is required for nuclear import of the Mig2 repressor
by: Fernández-Cid Alejandra, et al.
Published: (2012-11-01)